Causes of end-stage renal failure in black patients starting renal replacement therapy

American Journal of Kidney Diseases

Volumn 36, Issue 2, 2000, Pages 301-309

  Fernandes, Paula Frassinetti ^a   Ellis, Peter A ^a   Roderick, Paul J ^b   Cairns, Hugh S ^d   Hicks, Jackie A ^c   Stewart Cameron, J ^c  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^d Centra de Pesquisas em Doencas Hepato Renais ^*  (Brazil)

Author keywords

Black race; Cause of end stage renal failure (ESRF); Epidemiology; Ethnicity; Hypertension; Validation

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; ETHNIC GROUP; FEMALE; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEGRO; RACE DIFFERENCE;

EID: 0034255635     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2000.8974     Document Type: Article

References (29)

1. US Renal Data System: USRDS 1996 Annual Data Report: II. Incidence and prevalence of ESRD. Am J Kidney Dis 28:S34-S47, 1996 (suppl 2)
2. Roderick PJ, Raleigh VS, Hallam L, Mallick NP: The need and demand for renal replacement therapy in ethnic minorities in England. J Epidemiol Commun Health 50:334-339, 1996
3. Roderick PJ, Stonkey M, Clement S, Raleigh VS, Diamond I: Estimating the demand for renal replacement therapy in Greater London: The impact of demographic trends in African-Caribbeans and Asian populations. Health Trends 30:46-50, 1998
4. Easterling RE: Racial factors in the incidence and causation of end-stage renal disease. Trans Am Soc Artif Intern Organs 23:28-32, 1977
5. Relman AS: Race and end-stage renal disease. N Engl J Med 27:1290-1291, 1982
6. Fergusson R, Grim CE, Opgenorth TJ: The epidemiology of end-stage renal disease: The six year South-Central Los Angeles experience. Am J Public Health 77:684-685, 1987
7. McClellan W, Tuttle E, Issa A: Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 12:285-290, 1988
8. Smith SR, Svetkey LP, Dennis VW: Racial differences in the incidence and progression of renal diseases. Kidney Int 40:815-822, 1991
9. Feldman HI, Klag MJ, Chiapella AP, Whelton PK: End-stage renal disease in US minority groups. Am J Kidney Dis 19:397-410, 1992
10. Lopes AAS, Port FK, James AS, Agodoa L: The excess risk of treated end-stage renal disease in blacks in the United States. J Am Soc Nephrol 3:1961-1971, 1993
11. Whelton PK, Klag MJ: Hypertension as a risk factor for renal disease: Review of clinical and epidemiological evidence. Hypertension 13:S119-S127, 1989(suppl 1)
12. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM: Disparities in incidence of diabetic endstage renal disease according to race and type of diabetes. N Engl J Med 321:1074-1079, 1989
13. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ: The excess incidence of diabetic end-stage renal disease among blacks. JAMA 268:3079-3084, 1992
14. Pazanias M, Eastwood JB, Macrae KD, Phillips ME: Racial origin and primary renal diagnosis in 771 patients with end-stage renal disease. Nephrol Dial Transplant 6:931-935, 1991
15. Clark TJ, Richards NT, Adu J, Michael J: Increased prevalence of dialysis-dependent renal failure in ethnic minorities in the West Midlands. Nephrol Dial Transplant 8:146-148, 1993
16. Byrne C, Vernon P: Validation of the cause of renal failure of patients in the Medicare End-Stage Renal Disease Program. Am J Kidney Dis 18:375-378, 1991
17. Whittle JC, Whelton PK, Seidler AJ, Klag MJ: Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med 151:1359-1364, 1991
18. Pemeger TV, Whelton PK, Klag MJ, Rossiter KA: Diagnosis of hypertensive end-stage renal disease: Effect of patient's race. Am J Epidemiol 141:10-15, 1995
19. Balajaran R, Raleigh VS: The ethnic populations of England and Wales: The 1991 census. Health Trends 24:113-116, 1992
20. Senior PA, Bhopal R: Ethnicity as a variable in epidemiological research. BMJ 309:327-330, 1994
21. World Health Organization: WHO Technical Report Series: Arterial Hypertension. World Health Organ Tech Rep Ser 628:7-56, 1978
22. World Health Organization: WHO Technical Report Series: Diabetes mellitus: Definition, diagnosis and classification. World Health Organ Tech Rep Ser 777:9-21, 1985
23. Raleigh VS: Diabetes and hypertension in Britain's ethnic minorities: Implications for the future of renal services. BMJ 314:209-213, 1997
24. Stephens GW, Gillapsy JA, Clyne D, Mejia A, Pollak VE: Racial differences in the incidence of end-stage renal disease in type I and II diabetes mellitus. Am J Kidney Dis 15:562-567, 1990
25. Amos AF, McCarty DJ, Zimmet P: The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabetes Med 14:S7-S85, 1997 (suppl 5)
26. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
27. Schlessinger SD, Tankersley MR, Curtis JJ: Clinical documentation of end-stage renal disease due to hypertension. Am J Kidney Dis 23:655-660, 1994
28. Balarajan R, Raleigh VS: Ethnicity and Health in England. London, England, HMSO, 1995
29. Yium J, Gabow P, Johnson A, Kimberling W, Martinez-Maldonado M: Autosomal dominant polycystic kidney disease in blacks: Clinical course and effects of sickle-cell hemoglobin. J Am Soc Nephrol 4:1670-1674, 1994